好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, February 23, 2022

Having a Poor Score on a Simple Memory Test May Be Linked to Alzheimer鈥檚 Biomarkers

MINNEAPOLIS - Among people with no memory or thinking problems, having a poor score on a simple memory test may be linked to biomarkers in the brain associated with Alzheimer鈥檚 disease as well as very early signs of memory impairment that precede dementia by several years, according to a study published in the February 23, 2022, online issue of , the medical journal of the 好色先生. 鈥淭hese findings suggest that this test can be used to improve our ability to detect cognitive decline in the stage before people are diagnosed with Alzheimer鈥檚 disease,鈥 said study author Ellen Grober, PhD, of Albert Einstein College of Medicine in the Bronx, New York. 鈥淭his could be helpful in determining who to enroll in clinical trials for prevention of cognitive decline. It could also help by narrowing down those who already have signs of Alzheimer鈥檚 in the brain with a simple test rather than expensive or invasive scans or lumbar punctures.鈥 For the test, people are shown pictures of items and given cues about the item鈥檚 category, such as a picture of grapes with the cue of 鈥渇ruit.鈥 Then participants are asked to remember the items, first on their own, then with the category cues for any items they did not remember. This type of controlled learning helps with the mild memory retrieval problems that occur in many healthy elderly people but does not have much impact on memory for people with dementia, Grober said. The study involved 4,484 people with no cognitive problems and an average age of 71. The participants were divided into five groups based on their scores on the test, or stages zero through four. Stages zero through two reflect increasing difficulty with retrieving memories or items learned and precede dementia by five to eight years. In these stages, people have increasing trouble remembering the items on their own, but they continue to be able to remember items when given cues. In the third and fourth stages, people cannot remember all of the items even after they are given cues. These stages precede dementia by one to three years. The study participants also had brain scans to look for the beta-amyloid plaques in the brain that are markers of Alzheimer鈥檚 disease, as well as to measure the volume of areas of the brain associated with Alzheimer鈥檚 pathology. Half of the participants had no memory issues. Half had retrieval issues, issues for storage of memories or both. The researchers found that people who tested in the third and fourth stages were likely to have higher amounts of beta-amyloid in their brains than people in the lower stages. They were also more likely to have a lower volume in the hippocampus and other areas of the brain associated with Alzheimer鈥檚 pathology. At stage zero, 30% of people had beta-amyloid plaques, compared to 31% at stage one, 35% at stage two, 40% at stage three and 44% at stage four. Grober said, 鈥淭his system allows us to distinguish between the following: the difficulty people have retrieving memories when they are still able to create and store memories in their brains, which occurs in the very early stages before dementia can be diagnosed; and the memory storage problems that occur later in this predementia phase when people can no longer store the memories in their brains.鈥 A limitation of the study was that the participants had a high level of education, so the results may not be applicable to the general population. The study was supported by the National Institutes of Health, Alzheimer鈥檚 Association, Cure Alzheimer Fund and Leonard and Sylvia Marx Foundation using publicly available data from the A4 study. Learn more about brain health at , home of the 好色先生鈥檚 free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life on , and . When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life庐, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.


The 好色先生 is the leading voice in brain health. As the world鈥檚 largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN鈥檚 mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at or find us on , , , and .

For More Information*

Email media@aan.com

*While content of the 好色先生 (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver magazine website, .